Brief: Protara Therapeutics Presents Results From Analysis Of Studies Of OK-432 In Patients With Lymphatic Malformations

Protara Therapeutics

12/05/2022 13:24

May 12 (Reuters) - Protara Therapeutics Inc  TARA.O :
    * PROTARA THERAPEUTICS PRESENTS RESULTS FROM RETROSPECTIVE
ANALYSIS OF RANDOMIZED AND OPEN-LABEL STUDIES EVALUATING THE
SAFETY AND EFFICACY OF OK-432 IN PATIENTS WITH LYMPHATIC
MALFORMATIONS
    * PROTARA THERAPEUTICS INC - FINDINGS INCLUDE APPROXIMATELY
69% OF
PATIENTS IN RANDOMIZED STUDY ITG ACHIEVED CLINICAL SUCCESS AFTER
SIX MONTHS
    * PROTARA THERAPEUTICS INC - FINDINGS INCLUDE 73.1% OF
PATIENTS IN
OPEN-LABEL STUDY ACHIEVED CLINICAL SUCCESS

Source text for Eikon:  ID:nGNXbC7sjx 
Further company coverage:  TARA.O 

 ((Reuters.Briefs@thomsonreuters.com;))